Pricing Log in Create free account
Saturday 17 October 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IDEXX Laboratories, Inc. (IDXX) EBITDA

Alert me on EBITDA

IDEXX Laboratories, Inc.'s EBITDA for fiscal 2025 was $1.5B, up 19.6% from $1.3B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.6B. Over the past ten years it has ranged from $370.3M (fiscal 2015) to $1.5B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 3 consecutive fiscal years. IDEXX Laboratories, Inc. ranks 7th of 52 Diagnostics & Research companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $1.5B 19.63%
FY2024 $1.3B 3.81%
FY2023 $1.2B 19.92%
FY2022 $1.0B (2.50%)
FY2021 $1.0B 31.13%
FY2020 $790.5M 23.35%
FY2019 $640.9M 11.55%
FY2018 $574.5M 15.79%
FY2017 $496.2M 15.58%
FY2016 $429.3M 15.93%

Quarterly newest first

Period EBITDA Change
Jun 2026 $466.6M 16.58%
Mar 2026 $400.3M 12.97%
Dec 2025 $354.3M (9.49%)
Sep 2025 $391.5M (4.24%)
42 more quarters

Against its own ten years

Low $370.3M High $1.5B
Ten-year median $790.5M
Current reading's percentile 100

EBITDA against peers

Company EBITDA
IQV IQVIA Holdings Inc. compare $3.4B
DGX Quest Diagnostics Incorporated compare $2.2B
LH Labcorp Holdings Inc. compare $2.2B
A Agilent Technologies, Inc. compare $1.9B
IDXX IDEXX Laboratories, Inc. $1.6B
MTD Mettler-Toledo International, Inc. compare $1.3B
ILMN Illumina, Inc. compare $1.2B
WAT Waters Corporation compare $942.8M
NTRA Natera, Inc. compare −$223.9M

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on IDXX